value-based care

Blog

Can Proactive Value-Based Care And ACOs Have An Impact On Amputation Prevention?

01/28/2021

Mark Hinkes DPM FACFAS FAPWCA DABFAS

In many countries, there is a single payer system, in which the government pays the cost of health care and the providers are on salary. In this model, there is no billing as providers merely provide the services mandated by the government...

In many countries, there is a...

01/28/2021

Podiatry Today

Perspectives

Approaching Clinical Pathway Development as an Art

11/18/2020

Richard G Stefanacci, DO, MGH, MBA, AGSF, CMD

Craig Ornstein, PhD

Seth Gordon, MBA

Abstract: In health care, rules and regulations are in place for good reason, but there is an art to integrating them into care effectively to benefit patients as well as the other stakeholders—clinically and...

...

11/18/2020

Journal of Clinical Pathways

News

Researchers Identify Predictors of Longer Hospital Stay for Patients Undergoing Allogeneic Transplant

08/18/2020

Among patients who undergo allogeneic hematopoietic stem cell transplant (allo-HSCT), hospital length of stay is a driver for increased cost and can be predicted using patient- and transplant-related characteristics,...

Among...

08/18/2020

Journal of Clinical Pathways

News

First-Year OCM Participation Associated With Fewer Visits, Lower Costs

08/13/2020

In the first year, cancer centers that implement payment models with shared-savings components can be associated with fewer visits and lower costs, however these savings are largely offset by the cost of program...

In the...

08/13/2020

Journal of Clinical Pathways

News

Frontline Immune Checkpoint Inhibitors Cost-Effective for Advanced Melanoma

08/07/2020

Nivolumab plus ipilimumab and pembrolizumab are the most cost-effective front-line treatment options for patients with newly diagnosed advanced melanoma and unknown BRAF status, according to a study published in JAMA...

...

08/07/2020

Journal of Clinical Pathways

Interview

MD Anderson, Philips Collaborate to Offer Personalized Care on a Global Scale

07/14/2020

In June 2020, The University of Texas MD Anderson Cancer Center and Royal Philips announced a collaboration to provide oncologists with biomarker-driven, evidence-based therapy and clinical trial guidance through...

In...

07/14/2020

Journal of Clinical Pathways

Interview

Elsevier’s ClinicalPath: Supporting Value-Based Care and the Path Forward

07/07/2020

In January 2018, Elsevier—an information analytics business specializing in science and health—acquired Via Oncology – a leading decision-support and clinical pathways vendor. Since that time, Elsevier has rebranded...

In...

07/07/2020

Journal of Clinical Pathways

News

CancerLinQ Certification Pathway Offers Automated Quality Reporting

06/25/2020

In June 2020, the American Society of Clinical Oncology (ASCO) launched the SmartLinQ Quality Oncology Practice Initiative (QOPI) Certification Pathway for practices participating in the QOPI Certification...

In...

06/25/2020

Journal of Clinical Pathways

Quality Outlook

Beyond Face Value: Why Indirect Benefits of Cancer Care Matter

05/27/2020

Tom Valuck, MD, JD, and colleagues shed light on the value of indirect benefits of effective cancer care and challenges of measuring such benefits, including insufficient data and patient-focused measures.

Tom Valuck, MD, JD, and...

05/27/2020

Journal of Clinical Pathways